Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSTEO-GRA trial of netazepide in postmenopausal women
PACTR202407466904092Phase 3Unknown
- Sponsor
- University of Cape Town
- Start
- Apr 2019
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Netazepide with Placebo (2 arms). Primary endpoint: CTX levels before and after GRA administration. Status: unknown.
02
Drugs
netazepide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on PACTR202407466904092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407466904092.